Position in UTHR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,686,934
+$327,183 QoQ
Shares Held
4,959
+2.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#331
of 870 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $12,861,475 across 15 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (20.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
4,959 | $2,686,934 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
111,861 | $1,620,865 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
8,171 | $1,377,140 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
81,606 | $1,308,144 | |
| 5 | VTRS |
Viatris Inc
|
71,967 | $1,142,835 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
7,926 | $879,310 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
23,551 | $797,907 | |
| 8 | ALKS |
Alkermes plc.
|
13,278 | $695,767 |
All Filings in UTHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,686,934 | 4,959 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $2,359,751 | 4,843 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,999,631 | 4,770 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,356,866 | 4,722 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $905,080 | 2,936 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $260,395 | 738 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $266,612 | 744 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $223,940 | 703 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $109,806 | 478 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $127,756 | 581 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $100,060 | 443 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $131,346 | 595 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $94,287 | 421 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $142,103 | 511 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $71,189 | 340 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $53,019 | 225 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $26,732 | 149 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $35,221 | 163 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $42,084 | 228 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $31,396 | 175 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $29,941 | 179 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $25,197 | 166 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $13,433 | 133 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $10,769 | 89 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $64,291 | 678 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||